Highlights
- Market Cap
- $1.65B
- Enterprise Value
- $1.55B
- EPS (TTM)
- -$0.30
- Total Revenue (TTM)
- $1.29B
- Gross Profit (TTM)
- $526.37M
- EBITDA (TTM)
- $217.96M
- Year Range
- $0.68 - $5.05
- Target Price
- $13.02
- ROA (TTM)
- -8.19%
- ROE (TTM)
- -30.82%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Curaleaf Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Curaleaf Holdings, Inc. (CURLF) has returned -15.08% so far this year and 135.16% over the past 12 months.
Curaleaf Holdings, Inc.
- 1D
- 13.23%
- 1M
- -8.15%
- YTD
- -15.08%
- 6M
- -23.30%
- 1Y
- 135.16%
- 3Y*
- -8.68%
- 5Y*
- -32.38%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Oct 29, 2018, CURLF's average daily return is +0.08%, while the average monthly return is +1.23%. At this rate, your investment would double in approximately 4.7 years.
Historically, 50% of months were positive and 50% were negative. The best month was Aug 2025 with a return of +144.4%, while the worst month was Oct 2023 at -35.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, CURLF closed higher 46% of trading days. The best single day was Dec 12, 2025 with a return of +37.9%, while the worst single day was Dec 18, 2025 at -32.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -12.30% | 5.43% | -8.15% | -15.08% | |||||||||
| 2025 | -15.38% | -0.76% | -30.53% | 18.30% | -22.90% | 1.59% | 60.10% | 144.44% | -15.45% | 1.08% | -19.08% | 10.43% | 61.54% |
| 2024 | 28.82% | -8.80% | 11.95% | 17.60% | -26.11% | -17.03% | 3.90% | -28.00% | 6.25% | -5.56% | -33.32% | -19.05% | -61.58% |
| 2023 | -10.64% | -5.99% | -22.16% | -8.90% | 11.72% | 8.11% | 20.31% | 0.54% | 20.86% | -35.51% | 19.73% | 16.33% | -5.52% |
| 2022 | -19.44% | -3.45% | 3.29% | -18.77% | 5.40% | -18.42% | 9.90% | 13.87% | -21.84% | 9.31% | 22.59% | -35.09% | -52.25% |
| 2021 | 11.10% | 19.17% | -4.35% | -6.99% | 4.53% | -4.37% | -14.58% | -1.16% | 1.26% | -19.09% | -2.14% | -5.67% | -24.82% |
Benchmark Metrics
Curaleaf Holdings, Inc. has an annualized alpha of 7.97%, beta of 0.88, and R² of 0.04 versus S&P 500 Index. Calculated based on daily prices since October 30, 2018.
- This stock participated in 149.96% of S&P 500 Index downside but only 57.75% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.04 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.97%
- Beta
- 0.88
- R²
- 0.04
- Upside Capture
- 57.75%
- Downside Capture
- 149.96%
Return for Risk
Risk / Return Rank
CURLF ranks 76 for risk / return — better than 76% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Curaleaf Holdings, Inc. (CURLF) and compare them to a chosen benchmark (S&P 500 Index).
| CURLF | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.10 | 0.90 | +0.20 |
Sortino ratioReturn per unit of downside risk | 2.24 | 1.39 | +0.86 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.21 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | 1.91 | 1.40 | +0.51 |
Martin ratioReturn relative to average drawdown | 3.80 | 6.61 | -2.81 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore CURLF risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Curaleaf Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Curaleaf Holdings, Inc. was 95.70%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Curaleaf Holdings, Inc. drawdown is 87.49%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.7% | Feb 17, 2021 | 1041 | Apr 8, 2025 | — | — | — |
| -76.59% | Apr 23, 2019 | 230 | Mar 19, 2020 | 179 | Dec 2, 2020 | 409 |
| -52.29% | Nov 5, 2018 | 21 | Dec 4, 2018 | 72 | Mar 21, 2019 | 93 |
| -18.76% | Apr 4, 2019 | 8 | Apr 15, 2019 | 3 | Apr 18, 2019 | 11 |
| -17.73% | Jan 15, 2021 | 8 | Jan 27, 2021 | 8 | Feb 8, 2021 | 16 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Curaleaf Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Curaleaf Holdings, Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CURLF relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CURLF has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CURLF in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CURLF has a P/B value of 2.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |